Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · IEX Real-Time Price · USD
0.897
+0.037 (4.35%)
At close: Apr 23, 2024, 4:00 PM
0.900
+0.003 (0.28%)
After-hours: Apr 23, 2024, 5:17 PM EDT
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $6.55 million as of April 23, 2024. Its market cap has increased by 104.55% in one year.
Market Cap
6.55M
Enterprise Value
4.02M
1-Year Change
104.55%
Ranking
Category
Stock Price
$0.90
Market Cap Chart
Since November 16, 2017, Enveric Biosciences's market cap has decreased from $137.90M to $6.55M, a decrease of -95.25%. That is a compound annual growth rate of -37.72%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 22, 2024 | 6.30M | -1.56% |
Apr 19, 2024 | 6.40M | -5.88% |
Apr 18, 2024 | 6.80M | 6.25% |
Apr 17, 2024 | 6.40M | -3.03% |
Apr 16, 2024 | 6.60M | -1.49% |
Apr 15, 2024 | 6.70M | -9.46% |
Apr 12, 2024 | 7.40M | 12.12% |
Apr 11, 2024 | 6.60M | -2.94% |
Apr 10, 2024 | 6.80M | -1.45% |
Apr 9, 2024 | 6.90M | 2.99% |
Apr 8, 2024 | 6.70M | -1.47% |
Apr 5, 2024 | 6.80M | -1.45% |
Apr 4, 2024 | 6.90M | -6.76% |
Apr 3, 2024 | 7.40M | -10.84% |
Apr 2, 2024 | 8.30M | 27.69% |
Apr 1, 2024 | 6.50M | -10.96% |
Mar 28, 2024 | 7.30M | -1.35% |
Mar 27, 2024 | 7.40M | -3.90% |
Mar 26, 2024 | 7.70M | 220.83% |
Mar 25, 2024 | 2.40M | -7.69% |
Mar 22, 2024 | 2.60M | -3.70% |
Mar 21, 2024 | 2.70M | - |
Mar 20, 2024 | 2.70M | -3.57% |
Mar 19, 2024 | 2.80M | 7.69% |
Mar 18, 2024 | 2.60M | 4.00% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Healthcare Triangle | 6.53M |
Creative Medical Technology Holdings | 6.53M |
Shuttle Pharmaceuticals Holdings | 6.48M |
Xenetic Biosciences | 6.47M |
Cadrenal Therapeutics | 6.43M |
OpGen | 6.31M |
eFFECTOR Therapeutics | 6.27M |
Ainos | 6.13M |